Neuvotion is developing breakthrough solutions for facilitating and restoring movement. Our approach combines targeted neurostimulation and AI (artificial intelligence) to deliver unparalleled therapeutic value for patients with a movement disorder or impairment from stroke or injury. Neuvotion products allow doctors and therapists to leverage state-of-the-art technology, while monitoring patient progress in-person or remotely.
The U.S. Outpatient Rehabilitation/Physical Therapy market is more than $30 billion today and projected to grow at more than 5% per year.
(U.S. Physical Therapy, Inc.)
We’re an experienced team of entrepreneurs, engineers, and AI experts with a groundbreaking approach to treating paralysis and movement disorders. At Neuvotion, we believe the right team, with the right level of experience and focus, can achieve revolutionary solutions. We are devoted to our mission to help patients and are constantly seeking valuable feedback from researchers, clinicians and patients in order to learn and evolve. Contact us today to learn more.
Prof. Chad Bouton
Founder and CEO
25+ years in biomedical engineering, medical device R&D, and commercialization; 70 patents; Innovator of the Year; Published in Nature
Rory Murphy, MD
20+ years in spinal cord injury and advanced surgeries; Neurosurgeon at Barrow Neurosurgical Institute
Sadegh Ebrahimi, PhD
Senior Electrical Engineer, AI Lead
Stanford-trained neural engineer, 10 years experience in neurotechnology and applied machine learning
Sandeep Singh, MD
25+ years in medicine
Expertise in SCI, stroke, movement disorders;
CMO, Good Shepherd Rehabilitation Services
Trevor Hawkins, PhD
25+ years in healthcare R&D and commercialization; Formerly with GE Ventures; Formerly Director of the Human Genome Project (DOE)
Frank Hyland, MS
35+ years in occupational and physical therapy, Expertise in SCI, stroke, Neurorehabilitation;
VP, Good Shepherd Rehabilitation Services